The global market for Atherosclerosis Drugs is currently valued at US$ 49.9 billion, and it is anticipated to grow at a compound annual growth rate (CAGR) of 2.3% over the next decade. By 2033, it is forecasted to reach US$ 62.8 billion.
Atherosclerosis, characterized by arterial plaque buildup, remains a major contributor to cardiovascular diseases worldwide. Factors such as...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek